Wang Xiaodong
Wang Xiaodong is a corporate insider at BeOne Medicines Ltd. (ONC) filing SEC Form 4 transactions. 325 transactions, totaling $0 in purchases and $140,327,655 in sales. Source: SEC EDGAR.
Wang Xiaodong (CIK 0001662982, 325 transactions) has one of the most structurally informative Form 4 files in the dataset: two nearly identical 542,880-share option exercises on BeiGene Ltd. (BGNE/ONC) at a $6.50 strike — first in May 2025 and again in June 2025 — while the ADR traded in the $220–$265 range, producing an in-the-money spread of roughly $140M–$145M per exercise. In each case he sold only a fraction of the exercised shares (≤42,000 shares at $222–$225 in May; ≤22,000 shares at $261–$265 in June), retaining the bulk of the exercised block. Across 2025 he then made two large gifts (code 'G') of 424,073 shares (November 2025) and 148,096 shares (September 2025) — totaling 572,169 shares of ONC with no disclosed price, consistent with a family-wealth or charitable distribution. Lifetime ONC sell aggregate of 872,654 shares against zero buys is misleadingly skewed by the option exercises (which inflate the buy count when processed) and the gifts; the honest read is an executive who has exercised deeply, gifted meaningfully, and retained most of his exposure rather than liquidating it.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 193,492 | $20.81 | $4.03M | 193,492 | 6/11/2026 Filed: 6/11/2026 | Filing → | |
| Award | 99,892 | - | - | 4,682,493 | 6/11/2026 Filed: 6/11/2026 | Filing → | |
| Gift | 424,073 | - | - | 4,582,601 | 11/7/2025 Filed: 11/12/2025 | Filing → | |
| Gift | 148,096 | - | - | 5,006,674 | 9/9/2025 Filed: 9/11/2025 | Filing → | |
| Sale | 100 | $267.81 | $27K | 0 | 6/24/2025 Filed: 6/25/2025 | Filing → | |
| Sale | 507 | $266.57 | $135K | 100 | 6/24/2025 Filed: 6/25/2025 | Filing → | |
| Sale | 1,100 | $265.35 | $292K | 607 | 6/24/2025 Filed: 6/25/2025 | Filing → | |
| Sale | 300 | $263.50 | $79K | 1,707 | 6/24/2025 Filed: 6/25/2025 | Filing → | |
| Exercise | 542,880 | - | - | 7 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Award | 185,796 | - | - | 185,796 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Sale | 100 | $264.85 | $26K | 0 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Sale | 6,787 | $264.08 | $1.79M | 100 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Sale | 16,094 | $263.17 | $4.24M | 6,887 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Sale | 15,878 | $262.20 | $4.16M | 22,981 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Sale | 2,901 | $261.20 | $758K | 38,859 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Exercise | 41,760 | $6.50 | $271K | 41,760 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Award | 98,696 | - | - | 5,180,861 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
BeiGene, Ltd. BGNE | Exercise | 542,880 | - | - | 542,887 | 5/13/2025 Filed: 5/15/2025 | Filing → |
BeiGene, Ltd. BGNE | Sale | 200 | $225.68 | $45K | 0 | 5/13/2025 Filed: 5/15/2025 | Filing → |
BeiGene, Ltd. BGNE | Sale | 10,104 | $224.32 | $2.27M | 200 | 5/13/2025 Filed: 5/15/2025 | Filing → |
Try asking...